Bladex Q3 2026 Net Income Rises 15% as Portfolio Hits Record
Bladex reported third-quarter 2026 net income of $63.2 million, up 15% year-over-year but down 5% sequentially, driven by record commercial portfolios and net interest income. Net interest margin rose to 2.30%, while adjusted return on equity reached 15.0%. Credit quality remained strong, with impaired credits at 0.4% and robust capital adequacy ratios well above regulatory minimums. Full-year 2026 guidance projects commercial portfolio growth near 35% and adjusted ROE between 14% and 15%. Key risks include rising impairment charges, higher year-over-year impaired-credit ratios, and rapid balance-sheet expansion impacting funding and capital management.
Bladex (BLX) reported third-quarter 2026 net income of $63.2 million, up 15% from a year earlier, as its commercial portfolio reached a record $15.0 billion and net interest income rose to a quarterly high. Profit declined 5% from the second quarter, while adjusted return on equity was 15.0%, compared with 16.5% in the prior quarter and 15.1% a year earlier.
For the first nine months of 2026, net income increased to $186.0 million from $170.9 million in the same period of 2025. Nine-month return on assets held at 1.9%, while adjusted ROE decreased to 15.2% from 16.3%.
Commercial portfolio and deposits reach records
The commercial portfolio, including loans, commercial bonds and contingencies, ended the quarter at $14.98 billion, up 38% year over year. The presentation showed sequential growth of 7% on a reported basis and 15% excluding a Panama government transaction.
The portfolio remained spread across countries and industries, although financial institutions represented 25% of exposure and oil and gas accounted for 18%. Other services and sovereign exposure made up 11%, while electric power represented 10%.
Average deposits increased 22% year over year and 6% quarter over quarter to $7.66 billion. Period-end deposits totaled $7.91 billion, representing 56% of the company’s $14.1 billion in funding sources. Total funding expanded 36% from a year earlier, with the balance also including long-term borrowings and debt, short-term funding, and securities sold under repurchase agreements.
Net interest income rises as margin improves sequentially
Net interest income reached a record $79.8 million, up from $73.3 million in the second quarter and $67.4 million a year earlier. Average interest-earning assets increased to $13.76 billion from $13.12 billion in the previous quarter and $11.53 billion in the prior-year period.
Net interest margin rose six basis points sequentially to 2.30%, although it remained two basis points below the year-earlier level. The net interest spread was unchanged from the second quarter at 1.64%, compared with 1.73% a year earlier.
Non-interest income totaled $19.3 million, a 26% increase year over year but a 25% decline from the second quarter. Net fees and commissions were $16.3 million, up 16% from the prior-year period. Operating expenses increased to $25.6 million from $23.8 million in the second quarter and $21.3 million a year earlier. The efficiency ratio was 25.8%, up 167 basis points sequentially and broadly unchanged year over year.
Credit quality remains strong, though impaired ratio is higher year over year
Stage 1 exposures accounted for 99.1% of the $16.6 billion credit portfolio, with 0.4% in Stage 2 and 0.5% in Stage 3. Impaired credits represented 0.4% of the portfolio, down eight basis points from the second quarter but up 29 basis points from a year earlier.
Total allowances for credit losses ended the quarter at $103.6 million, providing 138% coverage of impaired credits. The company recorded $9.5 million of impairment losses during the quarter, compared with an $11.0 million reversal in the second quarter.
Capital levels remained above the regulatory thresholds shown in the presentation. The Panama regulatory capital adequacy ratio was 14.3%, compared with a 10.5% minimum including the conservation buffer. The Basel III Tier 1 ratio was 16.2%, including a 14.4% common equity Tier 1 ratio, against a stated minimum of 9.25%.
Full-year guidance
Bladex’s updated full-year 2026 guidance calls for commercial portfolio growth of about 35% and average deposit growth of approximately 20%. Management expects a net interest margin of about 2.25%, an efficiency ratio near 27%, adjusted ROE of 14% to 15%, and a Tier 1 ratio in a range of 13% to 15%.
The presentation’s principal areas of uncertainty include the higher year-over-year impaired-credit ratio, the return to impairment charges after the second-quarter reversal, and sequential declines in net income and non-interest revenue. Rapid balance-sheet expansion also leaves funding, credit quality and capital management as important factors for the remainder of the year.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles










Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.